These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11488328)

  • 1. Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis. DAFNE Study Group.
    Miravitlles M; Murio C; Guerrero T
    Eur Respir J; 2001 May; 17(5):928-33. PubMed ID: 11488328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group.
    Grossman R; Mukherjee J; Vaughan D; Eastwood C; Cook R; LaForge J; Lampron N
    Chest; 1998 Jan; 113(1):131-41. PubMed ID: 9440580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group.
    Miravitlles M; Guerrero T; Mayordomo C; Sánchez-Agudo L; Nicolau F; Segú JL
    Respiration; 2000; 67(5):495-501. PubMed ID: 11070451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD.
    Miravitlles M; Murio C; Guerrero T; Gisbert R;
    Chest; 2002 May; 121(5):1449-55. PubMed ID: 12006427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis.
    Wilson R; Jones P; Schaberg T; Arvis P; Duprat-Lomon I; Sagnier PP;
    Thorax; 2006 Apr; 61(4):337-42. PubMed ID: 16449273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol.
    Matthys H; de Mey C; Carls C; Ryś A; Geib A; Wittig T
    Arzneimittelforschung; 2000 Aug; 50(8):700-11. PubMed ID: 10994153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous and on demand use of bronchodilators in patients with non-steroid dependent asthma and chronic bronchitis: four-year follow-up randomized controlled study.
    van Schayck CP; Dompeling E; van Herwaarden CL; Folgering H; Akkermans RP; van den Broek PJ; van Weel C
    Br J Gen Pract; 1995 May; 45(394):239-44. PubMed ID: 7619569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD.
    Adams SG; Melo J; Luther M; Anzueto A
    Chest; 2000 May; 117(5):1345-52. PubMed ID: 10807821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole P; Chong J; Cates CJ
    Cochrane Database Syst Rev; 2015 Jul; (7):CD001287. PubMed ID: 26222376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
    Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
    Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of ciprofloxacin compared with usual antibacterial care for the treatment of acute exacerbations of chronic bronchitis in patients followed for 1 year.
    Torrance G; Walker V; Grossman R; Mukherjee J; Vaughan D; La Forge J; Lampron N
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 1):499-520. PubMed ID: 10662396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment cost of acute exacerbations of chronic bronchitis.
    Niederman MS; McCombs JS; Unger AN; Kumar A; Popovian R
    Clin Ther; 1999 Mar; 21(3):576-91. PubMed ID: 10321424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
    Blasi F; Schaberg T; Centanni S; Del Vecchio A; Rosignoli MT; Dionisio P
    Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
    Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and Wales.
    McGuire A; Irwin DE; Fenn P; Gray A; Anderson P; Lovering A; MacGowan A
    Value Health; 2001; 4(5):370-5. PubMed ID: 11705127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with antibiotic use for acute bronchitis.
    Gonzales R; Barrett PH; Crane LA; Steiner JF
    J Gen Intern Med; 1998 Aug; 13(8):541-8. PubMed ID: 9734791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acute bacterial exacerbations of chronic bronchitis.
    Siempos II; Michalopoulos A; Falagas ME
    Expert Opin Pharmacother; 2009 May; 10(7):1173-82. PubMed ID: 19405791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-day telithromycin once daily is as effective as 10-day clarithromycin twice daily for the treatment of acute exacerbations of chronic bronchitis and is associated with reduced health-care resource utilization.
    Fogarty C; de Wet R; Mandell L; Chang J; Rangaraju M; Nusrat R
    Chest; 2005 Oct; 128(4):1980-8. PubMed ID: 16236845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The phenotype of concurrent chronic bronchitis and frequent exacerbations in patients with severe COPD attending Swedish secondary care units.
    Sundh J; Johansson G; Larsson K; Lindén A; Löfdahl CG; Sandström T; Janson C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2327-34. PubMed ID: 26604732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of HL301 in the treatment of acute bronchitis and acute exacerbation of chronic bronchitis: a phase 2, randomized, double-blind, placebo-controlled, multicenter study.
    Park MJ; Rhee CK; Kim YH; Kim DJ; Kim DG; Lee SY; Kim JY
    Curr Med Res Opin; 2017 May; 33(5):919-925. PubMed ID: 28277874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.